Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger By egalliNews, Press ReleasesNo Comments PRNewsWire Link Series B Preferred Stock investment made in Pulmatrix with a conversion price of $2.20 is a part of the ongoing merger process FRAMINGHAM, Mass., April 21, 2026 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the...Read More April 21, 2026